Follow institutional biosafety protocols
de la Harpe KM, Kondiah PPD, Choonara YE, Marimuthu T, du Toit LC, Pillay V
Personalization frameworks should include risk stratification and dose titration protocols
In another example, a 2023 report by market research firm Circana [1] , which tracks in-store purchases using scanner data purchased from retailers, found that GLP-1 users were scaling back purchases at a similar level to the average US household, with a marginal unit sales decline of 0.1% higher. The report did note, however, that households with a GLP-1 user were purchasing different items than non-GLP-1 households namely: high-protein, energy-boosting, hydration, and convenient snack products. GLP-1 medications have several side effects, including nausea and muscle loss